MedPath

The pharmacokinetics of lopinavir/ritonavir, nevirapine and efavirenz when given with isoniazid in South African HIV-infected individuals

Not Applicable
Recruiting
Conditions
HIV/AIDS
Tuberculosis
Registration Number
PACTR201206000391313
Lead Sponsor
niversity of Cape Town
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Stable on ART: efavirenz, nevirapine or lopinavir/ritonavir

Exclusion Criteria

Hepatitis
Pregnant
Using CYP450 inducers/inhibitors
Excessive alchol use
Intolerant to isoniazid

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.